Preventing neurotoxicity involves dose adjustments and the use of neuroprotective agents. The monitoring of neurological symptoms is critical for early intervention. In some cases, cessation of treatment or switching to a less neurotoxic agent may be necessary. Research into the mechanisms of cisplatin-induced neurotoxicity is ongoing, with the hope of developing effective preventive strategies.
